Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Nov 1;46(11):e209.
doi: 10.2337/dc23-1115.

Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005-1013

Marcelo Maia Pinheiro  1 , Felipe Moura Maia Pinheiro  2
Affiliations
Comment

Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005-1013

Marcelo Maia Pinheiro et al. Diabetes Care. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Comment in

Comment on

References

    1. Russell WE, Bundy BN, Anderson MS, et al. .; Type 1 Diabetes TrialNet Study Group . Abatacept for delay of type 1 diabetes progression in stage 1 relatives at risk: a randomized, double-masked, controlled trial. Diabetes Care 2023;46:1005–1013 - PMC - PubMed
    1. Pinheiro MM, Pinheiro FMM, Diniz SN, Fabbri A, Infante M. Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes. Int Immunopharmacol 2021;95:107518. - PubMed
    1. Pinheiro MM, Pinheiro FMM, de Arruda MM, et al. . Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study. Arch Endocrinol Metab 2023;67:e000652. - PMC - PubMed
    1. Rabinovitch A, Koshelev D, Lagunas-Rangel FA, et al. . Efficacy of combination therapy with GABA, a DPP-4i and a PPI as an adjunct to insulin therapy in patients with type 1 diabetes. Front Endocrinol (Lausanne) 2023;14:1171886. - PMC - PubMed
    1. Xu G, Grimes TD, Grayson TB, et al. . Exploratory study reveals far reaching systemic and cellular effects of verapamil treatment in subjects with type 1 diabetes. Nat Commun 2022;13:1159. - PMC - PubMed

MeSH terms